Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Amicus Therapeutics ApS
APS
Active
CVR 39359340
Rådhuspladsen 16, 1550
København V
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2018 · 8 years old
1 employees
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Amicus Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
1M
2M
2M
0M
2020
1M
2021
2M
2022
2M
2023
2M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
490
644
1.576
1.732
1.987
Staff expenses
-457
-607
-1.492
-1.636
-1.879
EBITDA
33
37
84
96
108
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
33
37
84
96
108
Net financials
-5
-12
-14
-29
-87
Profit before tax
28
25
69
67
21
Tax
6
5
15
15
5
Net profit
22
19
54
52
16
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
2.286
2.416
617
734
3.426
Equity
230
249
303
355
310
Long-term debt
0
0
0
0
0
Short-term debt
2.057
2.167
314
379
3.117
Total debt
2.057
2.167
314
379
3.117
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
5.4%
This company
2020
2024
Soliditetsgrad
9.0%
This company
38.2%
Market median
-76% vs market
2020
2024
Egenkapitalforrentning
5.3%
This company
18.4%
Market median
-71% vs market
2020
2024
Nettoresultatgrad (af bruttofortjeneste)
0.8%
This company
2020
2024
Aktivomsætning (af bruttofortjeneste)
0.58×
This company
2020
2024
Gæld/egenkapital
10.07×
This company
0.62×
Market median
-1524% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Amicus Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
